학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 6건 | 목록 1~10
Academic Journal
Ortiz-Barahona V; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Joshi RS; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Esteller M; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain. Electronic address: mesteller@carrerasresearch.org.
Publisher: Academic Press Country of Publication: England NLM ID: 9010218 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-3650 (Electronic) Linking ISSN: 1044579X NLM ISO Abbreviation: Semin Cancer Biol Subsets: MEDLINE
Academic Journal
Bueno-Costa A; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Piñeyro D; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), 28029, Madrid, Spain.; García-Prieto CA; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Barcelona Supercomputing Center (BSC), Barcelona, Catalonia, Spain.; Ortiz-Barahona V; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Martinez-Verbo L; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Webster NA; STORM Therapeutics Ltd, Cambridge, UK.; Andrews B; STORM Therapeutics Ltd, Cambridge, UK.; Kol N; Cancer Research Center and Wohl Institute for Translational Medicine, Chaim Sheba Medical Center, Tel-Hashomer, Israel.; Department of Human Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Avrahami C; Cancer Research Center and Wohl Institute for Translational Medicine, Chaim Sheba Medical Center, Tel-Hashomer, Israel.; Department of Human Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Moshitch-Moshkovitz S; Cancer Research Center and Wohl Institute for Translational Medicine, Chaim Sheba Medical Center, Tel-Hashomer, Israel.; Department of Human Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Rechavi G; Cancer Research Center and Wohl Institute for Translational Medicine, Chaim Sheba Medical Center, Tel-Hashomer, Israel.; Department of Human Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Esteller M; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain. mesteller@carrerasresearch.org.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), 28029, Madrid, Spain. mesteller@carrerasresearch.org.; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain. mesteller@carrerasresearch.org.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain. mesteller@carrerasresearch.org.
Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Academic Journal
Moubarak RS; Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.; Interdisciplinary Melanoma Cooperative Group, NYU Cancer Institute, New York, NY 10016, USA.; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, NY 10016, USA.; de Pablos-Aragoneses A; Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.; Ortiz-Barahona V; Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.; Gong Y; Applied Bioinformatics Laboratories, NYU School of Medicine, NY 10016, USA.; Gowen M; NYU School of Medicine Institute for Computational Medicine, New York, NY 10016, USA.; Dolgalev I; Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.; Applied Bioinformatics Laboratories, NYU School of Medicine, NY 10016, USA.; Shadaloey SAA; Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.; Interdisciplinary Melanoma Cooperative Group, NYU Cancer Institute, New York, NY 10016, USA.; Argibay D; Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.; Interdisciplinary Melanoma Cooperative Group, NYU Cancer Institute, New York, NY 10016, USA.; Karz A; Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.; Interdisciplinary Melanoma Cooperative Group, NYU Cancer Institute, New York, NY 10016, USA.; Von Itter R; Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.; Interdisciplinary Melanoma Cooperative Group, NYU Cancer Institute, New York, NY 10016, USA.; Vega-Sáenz de Miera EC; NYU School of Medicine Institute for Computational Medicine, New York, NY 10016, USA.; Sokolova E; Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.; Interdisciplinary Melanoma Cooperative Group, NYU Cancer Institute, New York, NY 10016, USA.; Darvishian F; Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.; Interdisciplinary Melanoma Cooperative Group, NYU Cancer Institute, New York, NY 10016, USA.; Tsirigos A; Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.; Applied Bioinformatics Laboratories, NYU School of Medicine, NY 10016, USA.; NYU School of Medicine Institute for Computational Medicine, New York, NY 10016, USA.; Osman I; Interdisciplinary Melanoma Cooperative Group, NYU Cancer Institute, New York, NY 10016, USA.; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, NY 10016, USA.; Ronald O. Perelman Department of Dermatology, NYU School of Medicine, New York, NY 10016, USA.; Hernando E; Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.; Interdisciplinary Melanoma Cooperative Group, NYU Cancer Institute, New York, NY 10016, USA.; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, NY 10016, USA.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE
Report
Esteve-Puig R; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.; Climent F; Department of Pathology, Bellvitge Biomedical Research Institute (IDIBELL), Hospital Universitari de Bellvitge, Universitat de Barcelona, L'Hospitalet, Barcelona, Spain.; Piñeyro D; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.; Centro de Investigación Biomédica en Red (CIBER) de Cáncer (CIBERONC), Madrid, Spain.; Domingo-Domènech E; Clinical Hematology Department, Catalan Institute of Oncology (ICO), Hospital Duran i Reynals, L'Hospitalet, Barcelona, Spain.; Davalos V; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.; Encuentra M; Clinical Hematology Department, Catalan Institute of Oncology (ICO), Hospital Duran i Reynals, L'Hospitalet, Barcelona, Spain.; Rea A; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.; Espejo-Herrera N; Department of Pathology, Bellvitge Biomedical Research Institute (IDIBELL), Hospital Universitari de Bellvitge, Universitat de Barcelona, L'Hospitalet, Barcelona, Spain.; Soler M; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.; Lopez M; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.; Ortiz-Barahona V; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.; Tapia G; Department of Pathology, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP) and.; Navarro JT; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.; Department of Hematology, Catalan Institute of Oncology (ICO), Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain.; Cid J; Apheresis and Cellular Therapy Unit, Department of Hemotherapy and Hemostasis (ICMHO), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Barcelona, Spain.; Farré L; Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Laboratory of Experimental Pathology (LAPEX), Gonçalo Moniz Research Center, Oswaldo Cruz Foundation (CPQGM/FIOCRUZ), Salvador, Brazil.; Villanueva A; Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Casanova I; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.; CIBER de Bioingeniería Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain.; Biomedical Research Institute Sant Pau (IIB-Sant Pau), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Mangues R; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.; CIBER de Bioingeniería Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain.; Biomedical Research Institute Sant Pau (IIB-Sant Pau), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Santamarina-Ojeda P; Nanomaterials and Nanotechnology Research Center-Spanish National Research Council (CINN-CSIC).; Health Research Institute of Asturias (ISPA).; Institute of Oncology of Asturias (IUOPA), and.; Department of Organisms and Systems Biology (B.O.S), University of Oviedo, Oviedo, Spain.; Fernández AF; Nanomaterials and Nanotechnology Research Center-Spanish National Research Council (CINN-CSIC).; Health Research Institute of Asturias (ISPA).; Institute of Oncology of Asturias (IUOPA), and.; Department of Organisms and Systems Biology (B.O.S), University of Oviedo, Oviedo, Spain.; Fraga MF; Nanomaterials and Nanotechnology Research Center-Spanish National Research Council (CINN-CSIC).; Health Research Institute of Asturias (ISPA).; Institute of Oncology of Asturias (IUOPA), and.; Department of Organisms and Systems Biology (B.O.S), University of Oviedo, Oviedo, Spain.; Piris MA; Centro de Investigación Biomédica en Red (CIBER) de Cáncer (CIBERONC), Madrid, Spain.; Service of Pathology, Fundación Jiménez Díaz University Hospital, Madrid, Spain.; Kol N; Cancer Research Center and.; Wohl Institute for Translational Medicine, Chaim Sheba Medical Center, Tel-Hashomer, Israel.; Department of Human Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Avrahami C; Cancer Research Center and.; Wohl Institute for Translational Medicine, Chaim Sheba Medical Center, Tel-Hashomer, Israel.; Department of Human Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Moshitch-Moshkovitz S; Cancer Research Center and.; Wohl Institute for Translational Medicine, Chaim Sheba Medical Center, Tel-Hashomer, Israel.; Department of Human Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Rechavi G; Cancer Research Center and.; Wohl Institute for Translational Medicine, Chaim Sheba Medical Center, Tel-Hashomer, Israel.; Department of Human Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sureda A; Clinical Hematology Department, Catalan Institute of Oncology (ICO), Hospital Duran i Reynals, L'Hospitalet, Barcelona, Spain.; Esteller M; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.; Centro de Investigación Biomédica en Red (CIBER) de Cáncer (CIBERONC), Madrid, Spain.; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain; and.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Spain.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Academic Journal
Janin M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Ortiz-Barahona V; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; de Moura MC; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Martínez-Cardús A; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Llinàs-Arias P; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Soler M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Nachmani D; Department of Medicine and Pathology, Cancer Research Institute, Beth Israel Deaconess Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Pelletier J; Molecular Mechanisms and Experimental Therapy in Oncology Program, Metabolism and Cancer Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Schumann U; EMBL-Australia Collaborating Group, Department of Genome Sciences, The John Curtin School of Medical Research, The Australian National University, Garran Road, Acton, ACT, 2601, Australia.; Calleja-Cervantes ME; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Moran S; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Guil S; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Bueno-Costa A; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Piñeyro D; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Perez-Salvia M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Rosselló-Tortella M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Piqué L; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Bech-Serra JJ; Proteomics Unit, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; De La Torre C; Proteomics Unit, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Vidal A; Department of Pathology, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.; Martínez-Iniesta M; Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), Oncobell Program, L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain.; Martín-Tejera JF; Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), Oncobell Program, L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain.; Villanueva A; Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), Oncobell Program, L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain.; Arias A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.; Cuartas I; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.; Aransay AM; Centro de Investigación Bimédica en Red de Enfermedades hepáticas y Digestivas (CIBERehd), CIC bioGUNE, 801A Bizkaia Technology Park, 48160, Derio, Spain.; La Madrid AM; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Catalonia, Spain.; Pediatric Neuro-Oncology Unit, Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Catalonia, Spain.; Carcaboso AM; Preclinical Therapeutics and Drug Delivery Research Program, Fundacio Sant Joan de Deu, Barcelona, Catalonia, Spain.; Santa-Maria V; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Catalonia, Spain.; Pediatric Neuro-Oncology Unit, Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Catalonia, Spain.; Mora J; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Catalonia, Spain.; Fernandez AF; Institute of Oncology of Asturias (IUOPA), Instituto de Investigación Sanitaria del Principado de Asturias (ISPA-FINBA), 33011, Oviedo, Spain.; Fraga MF; Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Universidad de Oviedo-Principado de Asturias, Oviedo, Spain.; Aldecoa I; Pathology-Brain Bank, Hospital Clínic de Barcelona-CDB-August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Catalonia, Spain.; Pedrosa L; Glioma and Neural Stem Cell Group and Translational Genomics and Targeted Therapeutics in Solid Tumors Team, IDIBAPS, Barcelona, Catalonia, Spain.; Graus F; Clinical and Experimental Neuroimmunology, IDIBAPS, Barcelona, Catalonia, Spain.; Vidal N; Department of Pathology, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain.; Martínez-Soler F; Faculty of Medicine and Health Sciences-Bellvitge, Universitat de Barcelona, IDIBELL, L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain.; Tortosa A; Faculty of Medicine and Health Sciences-Bellvitge, Universitat de Barcelona, IDIBELL, L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain.; Carrato C; Department of Pathology, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Catalonia, Spain.; Balañá C; Catalan Institute of Oncology, Hospital Germans Trias i Pujol, 08916, Badalona, Barcelona, Catalonia, Spain.; Boudreau MW; Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA.; Hergenrother PJ; Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA.; Kötter P; Institute for Molecular Biosciences, Goethe University, Frankfurt, Germany.; Entian KD; Institute for Molecular Biosciences, Goethe University, Frankfurt, Germany.; Hench J; Division of Neuropathology, Institute of Medical Genetics and Pathology, University Hospital Basel, 4031, Basel, Switzerland.; Frank S; Division of Neuropathology, Institute of Medical Genetics and Pathology, University Hospital Basel, 4031, Basel, Switzerland.; Mansouri S; Division of Neurosurgery, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada.; Zadeh G; Division of Neurosurgery, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada.; Dans PD; Joint IRB-BSC Program on Computational Biology, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), 08028, Barcelona, Catalonia, Spain.; Orozco M; Joint IRB-BSC Program on Computational Biology, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), 08028, Barcelona, Catalonia, Spain.; Department of Biochemistry and Biomedicine, University of Barcelona, 08028, Barcelona, Spain.; Thomas G; Molecular Mechanisms and Experimental Therapy in Oncology Program, Metabolism and Cancer Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain.; Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati Medical School, Cincinnati, OH, 45267-0508, USA.; Blanco S; CIC bioGUNE, 801A Bizkaia Technology Park, 48160, Derio, Spain.; Molecular Mechanisms Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC), University of Salamanca, 37007, Salamanca, Spain.; Seoane J; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.; Preiss T; EMBL-Australia Collaborating Group, Department of Genome Sciences, The John Curtin School of Medical Research, The Australian National University, Garran Road, Acton, ACT, 2601, Australia.; Victor Chang Cardiac Research Institute, Darlinghurst (Sydney), NSW, 2010, Australia.; Pandolfi PP; Department of Medicine and Pathology, Cancer Research Institute, Beth Israel Deaconess Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Esteller M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain. mesteller@carrerasresearch.org.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain. mesteller@carrerasresearch.org.; Department of Biochemistry and Biomedicine, University of Barcelona, 08028, Barcelona, Spain. mesteller@carrerasresearch.org.; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain. mesteller@carrerasresearch.org.; Josep Carreras Leukaemia Research Institute (IJC), Ctra de Can Ruti, Camí de les Escoles s/n, 08916, Badalona, Barcelona, Catalonia, Spain. mesteller@carrerasresearch.org.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Ortiz-Barahona, V.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어